STEEL GROVE CAPITAL ADVISORS, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
STEEL GROVE CAPITAL ADVISORS, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2023$5,100
-19.0%
10,0000.0%0.00%0.0%
Q1 2023$6,300
-99.6%
10,000
-99.6%
0.00%
-99.6%
Q4 2022$1,772,043
-4.6%
2,730,000
+152.8%
0.25%
-23.6%
Q3 2022$1,858,000
+76.4%
1,080,000
+27.1%
0.33%
+71.0%
Q2 2022$1,053,000849,5000.19%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders